Subscribe to MDT Magazine News

Watson Confirms District Court Ruling in Generic Fentora® Patent Suit

March 25, 2011 6:36 am | by Bio-Medicine.Org | Comments

MORRISTOWN, N.J., March 25, 2011 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ), today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No....


Bellicum Pharmaceuticals Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas

March 25, 2011 6:36 am | by Bio-Medicine.Org | Comments

HOUSTON, March 25, 2011 /- Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this...


Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes

March 25, 2011 6:34 am | by Bio-Medicine.Org | Comments

KATY, Texas, March 25, 2011 /PRNewswire-USNewswire/ -- Heyltex Corporation is the exclusive U.S. distributor of Radiogardase® (Prussian Blue insoluble capsules), the only FDA-approved drug to treat people who have been internally contaminated with radioactive cesium (Cs-137), which...


Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer

March 25, 2011 6:33 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., March 25, 2011 /- Mersana Therapeutics today announced  the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001 , a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line...


$2 Million Awarded to Duke University Prevention Epicenter to Study Reduction of Healthcare-Associated Infections Using Tru-D, Total Room Ultraviolet Disinfection

March 25, 2011 5:37 am | by Bio-Medicine.Org | Comments

DURHAM, N.C., March 25, 2011 /- Centers for Disease Control and Prevention has awarded $2 million to Duke University Prevention Epicenter as part of its program to conduct innovative research in the science of preventing Healthcare-Associated Infections, or HAIs, with the goal of saving...


AssureRx Health Raises $11 Million Series B Financing

March 25, 2011 4:34 am | by Bio-Medicine.Org | Comments

CINCINNATI, March 25, 2011 /- AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual...


Covaris Introduces Bench-top, AFA-based Process Technology

March 25, 2011 4:34 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., March 25, 2011 /- Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System. The SF220 system was designed to extend the company's ground-breaking Adaptive Focused Acoustics (AFA) technology to higher volume...


Aetna sues 6 NJ doctors for overbilling

March 25, 2011 2:45 am | by The Associated Press | Comments

Aetna Inc. is suing six New Jersey physicians, claiming they filed "unlawful and excessive" bills, including nearly $57,000 for a 25-minute consultation.The lawsuits stem from hospital care where patients were referred to in-network hospitals but received care from out-of-network physicians....


Inadequate diet can lead to anemia in postmenopausal women

March 24, 2011 9:38 pm | by EurekAlert | Comments

(Elsevier Health Sciences) A new study published in the April 2011 issue of the Journal of the American Dietetic Association indicates that inadequate nutrition is linked to a greater risk of anemia in postmenopausal women.


Higher prevalence of psychiatric symptoms found in children with epilepsy

March 24, 2011 9:38 pm | by EurekAlert | Comments

(Wiley-Blackwell) A newly published report reveals that children with epilepsy are more likely to have psychiatric symptoms, with gender a determining factor in their development. Findings showed that girls had more emotional problems, while boys had more hyperactivity/inattention...


STMicroelectronics unveils next-generation iNEMO? engine; Enables new level of motion-sensing applications on smart consumer devices

March 24, 2011 9:38 pm | by I-Micronews | Comments

Exciting fusion of motion-sensor data gives smartphone handsets, tablets and gaming devices new utility and features.

Finisar offers to acquire Ignis

March 24, 2011 9:37 pm | by I-Micronews | Comments

Fiber-optic communications component and subsystem maker Finisar Corp of Sunnyvale, CA, USA has entered into a transaction agreement to make a recommended voluntary public cash offer to acquire all of the outstanding shares of Ignis ASA of Oslo, Norway not currently owned by Finisar for...

Making Targeted Cancer Drugs Work Better

March 24, 2011 8:36 pm | by Massachusetts Institute of Technology | Comments

Researchers look beyond genetics to discover what makes some lung cancer patients respond to certain drugs.

Edwards Lifesciences added to S & P 500

March 24, 2011 5:45 pm | by The Associated Press | Comments

Standard & Poor's said Thursday that Edwards Lifesciences Corp. will replace Qwest Communications International Inc. on the S&P 500 index, one of several upcoming changes to S&P's indexes.Qwest will be dropped from the S&P 500 at the close of regular trading on March 31, when the company's...

HealthSpring to sell up to 8.6 million shares

March 24, 2011 4:45 pm | by The Associated Press | Comments

Health insurer HealthSpring Inc., which sells managed-care Medicare plans in several states and offers national Medicare prescription drug coverage, said Thursday it would issue new stock and use at least half the proceeds to pay down debt.The company said it would sell 7.5 million shares and...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.